Top 5 Infectious Disease Stories Week of March 23

News
Article

FDA authorizes Ito Invivyd’s pemivibart (Pemgarda), insights on Sofosbuvir levels in pregnant women, the effectiveness of fidaxomicin vs vancomycin for CDI treatment, and more this week from Contagion.

Recent Videos
A panel of 5 experts on C. difficile infections
A panel of 5 experts on C. difficile infections
A panel of 5 experts on C. difficile infections
Related Content
Investigational Live Biotherapeutic Product Significantly Reduces Risk of Recurrent Clostridioides difficile

Investigational Live Biotherapeutic Product Significantly Reduces Risk of Recurrent Clostridioides difficile

Contagion Editorial Team
January 24th 2025
Article
C difficile, Antimicrobials, and the Patients Most Affected

C difficile, Antimicrobials, and the Patients Most Affected

Nina Cosdon
November 23rd 2022
Podcast
Contagion's 2024 Top Stories: C difficile

Contagion's 2024 Top Stories: C difficile

Contagion Editorial Team
December 28th 2024
Article
Could the Flight or Fight Response Trigger Severe C difficile?

Could the Flight or Fight Response Trigger Severe C difficile?

John Parkinson
December 26th 2024
Article
Top 5 Infectious Disease News Stories Week of December 14-20

Top 5 Infectious Disease News Stories Week of December 14-20

Sophia Abene
December 21st 2024
Article
While Hospital-Acquired C difficile Cases Have Decreased, Community-Acquired Cases Have Risen

While Hospital-Acquired C difficile Cases Have Decreased, Community-Acquired Cases Have Risen

Sophia Abene;Joseph Zackular, PhD
December 18th 2024
Article
© 2025 MJH Life Sciences

All rights reserved.